ARCALYST - European Union Trademark Information

ARCALYST trademark registration was filed on December 19, 2011, and the mark was successfully registered with the EUIPO on April 9, 2014 under EUTM trademark no. 010505097.

Regeneron Pharmaceuticals, Inc., who is the trademark holder was represented by J A KEMP (EUIPO registered representative, ID no. 10662).

Across the opposition process there was 1 opposition raised. It was filed by BIOFARMA, société par actions simplifiée on April 23, 2012. GEVERS FRANCE was the opponent's representative.

Expiration date for the current trademark registration is December 19, 2021.

TRADEMARK INFORMATION
Trademark Name ARCALYST Trademark No. 010505097
Type Figurative Status Registered
Filling Date December 19, 2011 Registration Date April 9, 2014
NICE Classes 5 Basis EUTM
Reference TM26871JAF/CS Status Date April 11, 2014
Owner Information
Owner Regeneron Pharmaceuticals, Inc.
Owner ID 136681
Legal Status Legal entity
Country US
Address Regeneron Pharmaceuticals, Inc.
777 Old Saw Mill River Road
Tarrytown, NY 10591-6707
UNITED STATES
Representative Information
Representative J A KEMP
Representative ID 10662
Legal Status Legal person
Country GB
Address J A KEMP
14 South Square
Gray's Inn
London WC1R 5JJ
UNITED KINGDOM
NICE CLASS Descriptions
Class Class Description
5
Pharmaceutical, Veterinary Products, Dietetic

Pharmaceutical and medicinal preparations provided in injectable form for the regulation of immune and inflammatory responses, all of which must be stored refrigerated.

Disclaimer: The information provided on this page is considered public information by the European Union Intellectual Property Office and is provided for informational purposes only. It should not be construed as legal advice on any subject matter.